[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2952825B1 - Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2 - Google Patents

Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2

Info

Publication number
FR2952825B1
FR2952825B1 FR0958313A FR0958313A FR2952825B1 FR 2952825 B1 FR2952825 B1 FR 2952825B1 FR 0958313 A FR0958313 A FR 0958313A FR 0958313 A FR0958313 A FR 0958313A FR 2952825 B1 FR2952825 B1 FR 2952825B1
Authority
FR
France
Prior art keywords
virus
hsv3
vzv
hsv2
hsv1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0958313A
Other languages
English (en)
Other versions
FR2952825A1 (fr
Inventor
Goaster Jacqueline Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0958313A priority Critical patent/FR2952825B1/fr
Priority to PCT/EP2010/068126 priority patent/WO2011064254A1/fr
Publication of FR2952825A1 publication Critical patent/FR2952825A1/fr
Application granted granted Critical
Publication of FR2952825B1 publication Critical patent/FR2952825B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0958313A 2009-11-24 2009-11-24 Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2 Expired - Fee Related FR2952825B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0958313A FR2952825B1 (fr) 2009-11-24 2009-11-24 Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2
PCT/EP2010/068126 WO2011064254A1 (fr) 2009-11-24 2010-11-24 Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958313A FR2952825B1 (fr) 2009-11-24 2009-11-24 Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2

Publications (2)

Publication Number Publication Date
FR2952825A1 FR2952825A1 (fr) 2011-05-27
FR2952825B1 true FR2952825B1 (fr) 2012-05-25

Family

ID=42102368

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0958313A Expired - Fee Related FR2952825B1 (fr) 2009-11-24 2009-11-24 Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2

Country Status (2)

Country Link
FR (1) FR2952825B1 (fr)
WO (1) WO2011064254A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7103524A (fr) 1970-04-28 1971-11-01
NZ220645A (en) 1986-06-20 1989-10-27 Merck & Co Inc Modified varicella-zoster virus and its cultivation
WO1993024616A1 (fr) 1992-06-04 1993-12-09 Merck & Co., Inc. Procede de production d'un vaccin attenue contre l'herpesvirus varicellae
GB0504436D0 (en) 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
FR2952825A1 (fr) 2011-05-27
WO2011064254A1 (fr) 2011-06-03

Similar Documents

Publication Publication Date Title
HRP20182194T1 (hr) Onkolitički herpes simpleks virus i njegova terapeutska uporaba
PT2217230T (pt) Prevenção e tratamento de infeções secundárias após infeção viral
EP2536425A4 (fr) Vaccins destinés à être utilisés pour la prophylaxie et le traitement d'une maladie liée au virus de la grippe
IL212984A (en) Vaccines to treat or reduce the risk of mammalian viral infection containing at least two differentiated optimized HIV-1 viral polypeptides and drugs containing them
IL216508A (en) Vaccines against herpes simplex virus type 1 and / or 2 and their preparations and uses
HK1203944A1 (zh) 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類
ZA201308746B (en) Quinazoline derivatives for the treatment of viral infections and further diseases
HK1210152A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 6-
GB2446721B (en) Herpes simplex viruses and methods of viral replication
EP2114449A4 (fr) Vaccins combines de sous-unites du virus herpes simplex et methodes d'utilisation
EP2223934A4 (fr) Procédés d'inhibition d'une infection par le virus de la grippe et leurs médicaments
BRPI1012951A2 (pt) "administração de interferon para profilaxia ou tratamento de infecção por patôgeno"
ZA201303610B (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
EP2566957B8 (fr) Vaccin contre une infection à virus herpès bêta et utilisation correspondante
PL2521562T3 (pl) Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych
WO2011079073A3 (fr) Vaccins anti-virus herpès simplex
EP2633865A4 (fr) Utilisation d'interleukine 22 dans le traitement d'une hépatite virale
ZA201205547B (en) Therapies for treating hepatitis c virus infection
SI2694087T1 (sl) Zdravljenje zaradi infekcije z virusom hepatitisa B samim ali v kombinaciji z virusom hepatitisa delta in povezanih jetrnih obolenj
EP2373329A4 (fr) Utilisation d'inhibiteurs du facteur de croissance épidermique dans le cadre du traitement d'une infection virale
ZA201400940B (en) Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
FR2952825B1 (fr) Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2
EP2511368A4 (fr) Virus recombiné de la rougeole utile comme vaccin bivalent protégeant contre la rougeole et une infection par le virus nipah
ZA201205639B (en) Compositions and methods for treating hepatitis b virus infection
EP2511367A4 (fr) Virus recombiné de la rougeole utile comme vaccin bivalent protégeant contre la rougeole et une infection paludéenne

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20220705